Cargando…

Predicting treatable traits for long-acting bronchodilators in patients with stable COPD

PURPOSE: There is currently no measure to predict a treatability of long-acting β-2 agonist (LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive pulmonary disease (COPD). We aimed to build prediction models for the treatment response to these bronchodilators, in or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Jieun, Kim, Ki Tae, Lee, Ji-Hyun, Kim, Eun Kyung, Kim, Tae-Hyung, Yoo, Kwang Ha, Lee, Jae Seung, Kim, Woo Jin, Kim, Ju Han, Oh, Yeon-Mok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732547/ https://www.ncbi.nlm.nih.gov/pubmed/29263660 http://dx.doi.org/10.2147/COPD.S151909

Ejemplares similares

The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease
por: Shin, Hong-Joon, et al.
Publicado: (2021)

Treatment of severe stable COPD: the multidimensional approach of treatable traits
por: van Dijk, Marlies, et al.
Publicado: (2020)

Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV(1) level: a patient-level pooled analysis of phase-3 randomized clinical trials
por: Kang, Jieun, et al.
Publicado: (2021)

Treatable Traits in COPD – A Proposed Approach
por: Cardoso, João, et al.
Publicado: (2021)

Association of blood eosinophils and plasma periostin with FEV(1) response after 3-month inhaled corticosteroid and long-acting beta(2)-agonist treatment in stable COPD patients
por: Park, Hye Yun, et al.
Publicado: (2015)

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
por: Lee, Se Hee, et al.
Publicado: (2019)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Eosinophilia as a treatable trait in three patients with asthma and COPD
por: Ramsahai, James Michael, et al.
Publicado: (2018)

Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?
por: Cazzola, Mario, et al.
Publicado: (2023)

Assessment of Bronchodilator Responsiveness Following Methacholine-Induced Bronchoconstriction in Children With Asthma
por: Bauer, Siegfried, et al.
Publicado: (2011)

Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007)

COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014)

Spirometry and Bronchodilator Test
por: Sim, Yun Su, et al.
Publicado: (2017)

Heterogeneity of asthma and COPD overlap
por: Kim, Min-Hye, et al.
Publicado: (2018)

Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
por: Kim, Sae Ahm, et al.
Publicado: (2016)

Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Hwang, Jae-Joon, et al.
Publicado: (2020)

Asthma, COPD & ACOS: -Omics Approach to Refine Treatable Traits in These Conditions
por: CHUNG, Kian Fan
Publicado: (2017)

Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
por: David, Benjamin, et al.
Publicado: (2021)

The use of treatable traits to address COPD complexity and heterogeneity and to inform the care
por: Duszyk, Katarzyna, et al.
Publicado: (2021)

Establishing Quality of Life in Southern Taiwan COPD Patients Using Long-Acting Bronchodilator
por: Chin, Pik-Qi, et al.
Publicado: (2022)

Sex and Treatable Traits in Severe Asthma
por: Park, Han-Ki, et al.
Publicado: (2021)

Bronchodilators use in patients with COPD
por: Dong, Yaa-Hui, et al.
Publicado: (2015)

Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators
por: Nicolini, Antonello
Publicado: (2012)

Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis
por: Cope, Shannon, et al.
Publicado: (2013)

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
por: Matera, Maria Gabriella, et al.
Publicado: (2015)

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
por: Donohue, James F, et al.
Publicado: (2019)

Blood eosinophil count as a prognostic biomarker in COPD
por: Oh, Yeon-Mok, et al.
Publicado: (2018)

A clinical prediction model for hospitalized COPD exacerbations based on “treatable traits”
por: Yii, Anthony C A, et al.
Publicado: (2019)

Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity
por: Choi, Joon Young, et al.
Publicado: (2023)

Efficacy and Safety of Roflumilast in Korean Patients with COPD
por: Lee, Jae Seung, et al.
Publicado: (2016)

Airway wall thickness is increased in COPD patients with bronchodilator responsiveness
por: Kim, Victor, et al.
Publicado: (2014)

Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives
por: Rhee, Chin Kook, et al.
Publicado: (2019)

Resting hyperinflation and emphysema on the clinical course of COPD
por: Kim, Yeon Wook, et al.
Publicado: (2019)

Effect of perioperative bronchodilator therapy on postoperative pulmonary function among lung cancer patients with COPD
por: Shin, Sun Hye, et al.
Publicado: (2021)

Asthma-COPD Overlap in Two Comprehensive Cohorts in Korea: Time to Move to Treatable Traits
por: Sohn, Kyoung-Hee
Publicado: (2022)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017)

Asthma-COPD Overlap Shows Favorable Clinical Outcomes Compared to Pure COPD in a Korean COPD Cohort
por: Park, Hye Jung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_76tajg9epk115ud7g3kgap4lvk